A Study to Determine the Immunogenicity and Safety Profile of CSL Limited's Influenza Virus Vaccine Compared to a US Licensed Comparator Influenza Virus Vaccine in a Pediatric Population
Clinical trial NCT00959049 · COMPLETED
Trial details
- NCT number
- NCT00959049
- Sponsor
- Seqirus
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-09-01
- Primary completion
- 2009-12-01
- Enrollment
- 1474
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.